Different infusion durations for preventing platinum-induced hearing loss in children with cancer-Reference-Cited by-同舟云学术

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Published:2018-07-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van As Jorrit W¹,van den Berg Henk²,van Dalen Elvira C²

Affiliation:

1. Emma Children's Hospital/Academic Medical Center; c/o Cochrane Childhood Cancer; PO Box 22660 Amsterdam Netherlands 1100 DD

2. Emma Children's Hospital/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010885.pub4/epdf/full

Reference37 articles.

1. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology;Coze;Journal of Clinical Oncology,1997

2. Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study;Bergeron;Pediatric Blood & Cancer,2005

3. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters;Lanvers-Kaminsky;Pediatric Blood & Cancer,2006

4. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss;Bertolini;Journal of Pediatric Hematology/Oncology,2004

5. Brock P Yoeman L Bellman S Pritchard J Ototoxicity in children treated with cis-platinum (CDDP) for germ cell (GCT) and other tumours Medical and Pediatric Oncology 1987 329 (abstract 138)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Platinum a Real Store of Wealth?;International Journal of Financial Studies;2022-08-18

2. The PERK/ATF4/CHOP signaling branch of the unfolded protein response mediates cisplatin-induced ototoxicity in hair cells;Drug and Chemical Toxicology;2022-02-17

3. Importance of the Infusion Order in the Treatment of Cancer;Chemotherapy Protocols and Infusion Sequence;2022

4. Upfront Treatment of Pediatric High-Risk Neuroblastoma With Chemotherapy, Surgery, and Radiotherapy Combination: The CCCG-NB-2014 Protocol;Frontiers in Oncology;2021-11-15

5. Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue;Bone Marrow Transplantation;2021-04-06